La recherche européenne ouvre la voie à la réparation des tissus humains
Quatre projets faisaient la Une d’un séminaire européen. Une dizaine de brevets ont été déposés.
Marie-Martine Buckens
- ABB LTD N45.280.51%
- ALCON N80.080.65%
- RICHEMONT N144.55-0.17%
- GEBERIT N590.60.82%
- GIVAUDAN N40060.18%
- HOLCIM N94.540.55%
- KUEHNE+NAGEL INT N179-2.61%
- LOGITECH N67.142.29%
- LONZA N5740.49%
- NESTLE N87.380.37%
- NOVARTIS N91.1-0.01%
- PARTNERS GROUP N1112.51.27%
- ROCHE GS259.4-0.19%
- SIKA N207.80.73%
- SONOVA HOLDING AG253.50%
- SWISS LIFE HOLDING AG N840.60.1%
- SWISS RE N149.70.37%
- SWISSCOM N536-0.74%
- UBS GROUP N25.880.43%
- ZURICH INSURANCE N578.2-0.82%
- ABB LTD N45.280.51%
- ALCON N80.080.65%
- RICHEMONT N144.55-0.17%
- GEBERIT N590.60.82%
- GIVAUDAN N40060.18%
- HOLCIM N94.540.55%
- KUEHNE+NAGEL INT N179-2.61%
- LOGITECH N67.142.29%
- LONZA N5740.49%
- NESTLE N87.380.37%
- NOVARTIS N91.1-0.01%
- PARTNERS GROUP N1112.51.27%
- ROCHE GS259.4-0.19%
- SIKA N207.80.73%
- SONOVA HOLDING AG253.50%
- SWISS LIFE HOLDING AG N840.60.1%
- SWISS RE N149.70.37%
- SWISSCOM N536-0.74%
- UBS GROUP N25.880.43%
- ZURICH INSURANCE N578.2-0.82%